Trials / Unknown
UnknownNCT01688024
Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
Phase 2 Study of Mitomycin C Therapy for Biliary Strictures in Patients With Primary Sclerosing Cholangitis
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- Sponsor
- Li, Zhiping, M.D. · Individual
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effectiveness and safety of mitomycin C in the treatment of primary sclerosing cholangitis (PSC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mitomycin C | |
| DRUG | Normal saline |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2017-09-01
- Completion
- 2019-09-01
- First posted
- 2012-09-19
- Last updated
- 2016-09-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01688024. Inclusion in this directory is not an endorsement.